Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology of type 2 diabetes.

A J Scheen1

  • 1Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman, Liège, Belgium. andre.scheen@chu.ulg.ac.be

Acta Clinica Belgica
|April 8, 2004
PubMed
Summary

Type 2 diabetes involves impaired insulin sensitivity and beta-cell function, influenced by genetics and environment. Emerging research highlights adipose tissue

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

Area of Science:

  • Endocrinology
  • Metabolic Syndrome
  • Diabetes Pathogenesis

Background:

  • Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder.
  • It stems from multifactorial causes, including genetic and environmental influences.
  • Key features include impaired carbohydrate and fat metabolism, affecting beta-cell function and insulin sensitivity in tissues like muscle, liver, and adipose tissue.

Purpose of the Study:

  • To explore the interplay between insulin resistance and beta-cell dysfunction in T2DM pathogenesis.
  • To investigate the role of adipose tissue in T2DM development.
  • To examine emerging paradigms linking obesity, insulin resistance, and T2DM risk.

Main Methods:

  • Review of existing literature on T2DM pathogenesis.
  • Analysis of the roles of genetic and environmental factors.
  • Examination of established and emerging hypotheses regarding adipose tissue function.

Main Results:

  • Both beta-cell dysfunction and reduced insulin sensitivity are crucial in T2DM.
  • Obesity, particularly central visceral adiposity, is strongly linked to T2DM.
  • Emerging paradigms include ectopic fat storage and adipose tissue as an endocrine organ.

Conclusions:

  • The mechanisms linking insulin resistance and beta-cell dysfunction in T2DM require further elucidation.
  • Adipose tissue plays a significant role in T2DM pathogenesis through various mechanisms.
  • Understanding these interactions is vital for addressing the growing diabetes epidemic.

Related Experiment Videos